Busch MP - Search Results

1

Persistence of primary drug resistance among recently HIV-1 infected adults.

Barbour JD, Hecht FM, Wrin T, Liegler TJ, Ramstead CA, Busch MP, Segal MR, Petropoulos CJ, Grant RM. Barbour JD, et al. Among authors: busch mp. AIDS. 2004 Aug 20;18(12):1683-9. doi: 10.1097/01.aids.0000131391.91468.ff. AIDS. 2004. PMID: 15280779

2

Detection of HIV-1 in Entamoeba histolytica without evidence of transmission to human cells.

Brown M, Reed S, Levy JA, Busch M, McKerrow JH. Brown M, et al. AIDS. 1991 Jan;5(1):93-6. doi: 10.1097/00002030-199101000-00014. AIDS. 1991. PMID: 2059366

3

Reduction in CD8+ cell noncytotoxic anti-HIV activity in individuals receiving highly active antiretroviral therapy during primary infection.

Stranford SA, Ong JC, Martinez-Marino B, Busch M, Hecht FM, Kahn J, Levy JA. Stranford SA, et al. Proc Natl Acad Sci U S A. 2001 Jan 16;98(2):597-602. doi: 10.1073/pnas.98.2.597. Epub 2001 Jan 2. Proc Natl Acad Sci U S A. 2001. PMID: 11136234 Free PMC article.

4

Use of the sensitive/less-sensitive (detuned) EIA strategy for targeting genetic analysis of HIV-1 to recently infected blood donors.

Machado DM, Delwart EL, Diaz RS, de Oliveira CF, Alves K, Rawal BD, Sullivan M, Gwinn M, Clark KA, Busch MP. Machado DM, et al. Among authors: busch mp. AIDS. 2002 Jan 4;16(1):113-9. doi: 10.1097/00002030-200201040-00014. AIDS. 2002. PMID: 11741169

5

Homogeneous quasispecies in 16 out of 17 individuals during very early HIV-1 primary infection.

Delwart E, Magierowska M, Royz M, Foley B, Peddada L, Smith R, Heldebrant C, Conrad A, Busch M. Delwart E, et al. AIDS. 2002 Jan 25;16(2):189-95. doi: 10.1097/00002030-200201250-00007. AIDS. 2002. PMID: 11807302

6

Use of laboratory tests and clinical symptoms for identification of primary HIV infection.

Hecht FM, Busch MP, Rawal B, Webb M, Rosenberg E, Swanson M, Chesney M, Anderson J, Levy J, Kahn JO. Hecht FM, et al. Among authors: busch mp. AIDS. 2002 May 24;16(8):1119-29. doi: 10.1097/00002030-200205240-00005. AIDS. 2002. PMID: 12004270 Clinical Trial.

7

Time trends in primary HIV-1 drug resistance among recently infected persons.

Grant RM, Hecht FM, Warmerdam M, Liu L, Liegler T, Petropoulos CJ, Hellmann NS, Chesney M, Busch MP, Kahn JO. Grant RM, et al. Among authors: busch mp. JAMA. 2002 Jul 10;288(2):181-8. doi: 10.1001/jama.288.2.181. JAMA. 2002. PMID: 12095382

8

Absence of HBV and HCV, HTLV-I and -II, and human herpes virus-8 activation after allogeneic RBC transfusion in patients with advanced HIV-1 infection.

Asmuth DM, Kalish LA, Laycock ME, Murphy EL, Mohr BA, Lee TH, Gallarda J, Giachetti C, Dollard SC, van der Horst CM, Grant RM, Busch MP; Viral Activation Transfusion Study Group. Asmuth DM, et al. Among authors: busch mp. Transfusion. 2003 Apr;43(4):451-8. doi: 10.1046/j.1537-2995.2003.00350.x. Transfusion. 2003. PMID: 12662277 Clinical Trial.

9

Development of a new less-sensitive enzyme immunoassay for detection of early HIV-1 infection.

Rawal BD, Degula A, Lebedeva L, Janssen RS, Hecht FM, Sheppard HW, Busch MP. Rawal BD, et al. Among authors: busch mp. J Acquir Immune Defic Syndr. 2003 Jul 1;33(3):349-55. doi: 10.1097/00126334-200307010-00009. J Acquir Immune Defic Syndr. 2003. PMID: 12843746

10

Increased human T-lymphotropic virus type II proviral load following highly active retroviral therapy in HIV-coinfected patients.

Murphy EL, Grant RM, Kropp J, Oliveira A, Lee TH, Busch MP. Murphy EL, et al. Among authors: busch mp. J Acquir Immune Defic Syndr. 2003 Aug 15;33(5):655-6. doi: 10.1097/00126334-200308150-00019. J Acquir Immune Defic Syndr. 2003. PMID: 12902815 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

716 results

Search Page

Filters